Vanda Reports Positive Phase 3 Results For HETLIOZ In Delayed Sleep-Wake Phase Disorder; Stock Up

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) announced positive topline results from its pivotal Phase 3 study of HETLIOZ (tasimelteon) in adults with Delayed Sleep-Wake Phase Disorder, a circadian rhythm disorder that causes people to fall asleep and wake much later than desire